November 4, 2016

Noted parasitologist Dennis Kyle named GRA Eminent Scholar at UGA

By James Hataway, The University of Georgia

Dennis Kyle, one of the nation's leading infectious disease researchers, will join the University of Georgia faculty as its newest Georgia Research Alliance Eminent Scholar.

Kyle, currently a Distinguished Health Professor at the University of South Florida, will join UGA on Jan. 3, 2017, as the GRA Eminent Scholar in Antiparasitic Drug Discovery. He also will serve as the new director of UGA's Center for Tropical and Emerging Global Diseases, which Daniel Colley, a professor of microbiology, has led since 2001.

Established in 1998, CTEGD is made up of a wide range of research programs focused on the development of medical and public health interventions for diseases that contribute enormously to global death, disability and instability—including malaria, sleeping sickness, cryptosporidiosis, schistosomiasis and Chagas disease.

"Dr. Kyle is one of the world's foremost authorities on malaria and other parasitic diseases," said President Jere W. Morehead. "I am pleased that he will be joining UGA to advance the worldwide reputation of CTEGD and to strengthen the university's partnerships across GRA institutions in the development of new drug therapies."

Kyle will have a joint appointment in the department of cellular biology in the Franklin College of Arts and Sciences and the department of infectious diseases in the College of Veterinary Medicine.

The Georgia Research Alliance has partnered with Georgia's research universities to recruit world-class scientists who foster science- and technology-based economic development since 1990. GRA also invests in technology in strategic areas, helps commercialize university-based inventions and facilitates collaboration among academia, business and government. Kyle will be the 17th active GRA Eminent Scholar at UGA and the fifth to join the university in the past two years.

More info